USPTO 2015–2025 USPTO PatentsView Foreign Corporation

Sanofi-aventis Deutschland Gmbh

USPTO PatentsView assignee record - 1,348 granted patents across 89 technology areas, active 2015–2025. Filing-trend and competitive-moat analysis cross-referenced to USPTO Patent Public Search. Primary class: A61M (DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY ; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY ; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR).

Compiled byPlainPatent Editorial, US Patent Intelligence Editorial Team · May 15, 2026

Explore the portfolio See the ranking

1,348

Total patents granted

CPC technology areas

16.3

Avg claims per patent

-32%

5-year filing velocity

The verdict

Sanofi-aventis holds 1,348 US patents across 89 technology areas, rank #320 of 50,000 tracked assignees.

#320
of 50,000 US assignees by volume: Top 2%
by Innovation Score (63.4/100): 16.3
avg claims per patent: -32%
filing velocity, last 5 yrs

Portfolio overview

Sanofi-aventis Deutschland Gmbh has been granted 1,348 US utility patents between 2015 and 2025, placing Sanofi-aventis Deutschland Gmbh at rank #320 across all assignees tracked by PlainPatent. This portfolio spans 89 distinct Cooperative Patent Classification (CPC) subclasses, averaging 16.3 claims per patent with primary concentration in A61M (DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY ; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY ; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR). As a Foreign Corporation, Sanofi-aventis Deutschland Gmbh is one of the broader-portfolio assignees in the PatentsView dataset. By volume, Sanofi-aventis sits between Delta Faucet Company (1,351 patents, rank #316) and Avago Technologies General IP (singapore) Pte. Ltd. (1,321 patents, rank #324) - the closest US assignees by grant volume. The composite Innovation Score of 63.4/100 blends portfolio volume, filing velocity, technology breadth, and claim depth into a single comparable measure drawn directly from USPTO PatentsView records.

Filing cadence tells the strategic story. Between 2020 and 2025 the company received 546 grants, compared with 802 in the 2015–2019 window, a -32% shift in five-year velocity. A cooling filing rate may reflect portfolio consolidation, shifting priorities, or reduced R&D throughput. The Foreign Corporation classification further shapes interpretation, since corporate, government, and individual filers pursue patents for materially different reasons.

Claim depth and technology breadth together indicate competitive posture. Sanofi-aventis Deutschland Gmbh's 16.3 average claims per patent sits within the typical range for solid legal coverage without excessive prosecution cost, while a multi-domain presence across 89 subclasses balances depth with breadth. Combined with portfolio volume, these signals let analysts, investors, and licensing professionals benchmark Sanofi-aventis Deutschland Gmbh against peers pursuing similar technology classes.

Delta Faucet

1,351
ACER Incorporated

1,350
Exxonmobil Chemic…

1,350
Beijing Bytedance…

1,348
Sanofi-aventis De… ◀

1,348
Harman Internatio…

1,341
Kubota

1,340
COOK Medical

1,327
Avago General IP…

1,321

What this shows Sanofi-aventis holds 1,348 patents at rank #320, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Sanofi-aventis

By rank, the assignees closest to #320 in granted patent volume.

Leaders in A61M (Devices FOR Introducing Media INTO)

Other assignees with the most granted patents in Sanofi-aventis's primary technology class.

Sanofi-aventis's Innovation Score vs. every tracked assignee

Composite of portfolio volume, filing velocity, technology breadth, and claim depth (0–100)

63 Top 2% higher than 98% of 50,000 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2015–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.

View data table

Sanofi-aventis Deutschland Gmbh patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2015	121	9.0%
2016	217	16.1%
2017	184	13.6%
2018	113	8.4%
2019	167	12.4%
2020	126	9.3%
2021	108	8.0%
2022	94	7.0%
2023	65	4.8%
2024	66	4.9%
2025	87	6.5%

Which technologies does Sanofi-aventis Deutschland Gmbh patent most?

A61M - DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY ; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY ; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR 1,159

Y10T - TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION 99

A61B - DIAGNOSIS; SURGERY; IDENTIFICATION 85

G16H - HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA 79

A61J - CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE 55

G01N - INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES 38

A61K - PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES 37

A61P - SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS 30

G01D - MEASURING NOT SPECIALLY ADAPTED FOR A SPECIFIC VARIABLE; ARRANGEMENTS FOR MEASURING TWO OR MORE VARIABLES NOT COVERED IN A SINGLE OTHER SUBCLASS; TARIFF METERING APPARATUS; MEASURING OR TESTING NOT OTHERWISE PROVIDED FOR 27

F04C - ROTARY-PISTON, OR OSCILLATING-PISTON, POSITIVE-DISPLACEMENT MACHINES FOR LIQUIDS ; ROTARY-PISTON, OR OSCILLATING-PISTON, POSITIVE-DISPLACEMENT PUMPS 27

G01F - MEASURING VOLUME, VOLUME FLOW, MASS FLOW OR LIQUID LEVEL; METERING BY VOLUME 20

B65D - CONTAINERS FOR STORAGE OR TRANSPORT OF ARTICLES OR MATERIALS, e.g. BAGS, BARRELS, BOTTLES, BOXES, CANS, CARTONS, CRATES, DRUMS, JARS, TANKS, HOPPERS, FORWARDING CONTAINERS; ACCESSORIES, CLOSURES, OR FITTINGS THEREFOR; PACKAGING ELEMENTS; PACKAGES 19

F16H - GEARING 16

G06V - IMAGE OR VIDEO RECOGNITION OR UNDERSTANDING 15

C07K - PEPTIDES 15

Top 15 of 89 technology areas

Patent Moat Analysis

Portfolio Volume Strong

Tech Breadth Multi-domain

Claim Depth Standard

Velocity Declining

Where it ranks

Overall rank by patents

#320

Across all tracked assignees

Innovation Score

63.4 out of 100

View all rankings →

Data Source

USPTO PatentsView, US granted patents 2015–2025

How is Innovation Score calculated?

Frequently Asked Questions

How many patents does Sanofi-aventis Deutschland Gmbh hold?

Sanofi-aventis Deutschland Gmbh holds 1,348 US granted patents filed between 2015 and 2025, spanning 89 technology areas.

What is Sanofi-aventis Deutschland Gmbh's Innovation Score?

Sanofi-aventis Deutschland Gmbh has an Innovation Score of 63.4 out of 100. This composite metric weighs portfolio volume (40%), filing velocity (20%), technology breadth (25%), and claim depth (15%).

What technology areas does Sanofi-aventis Deutschland Gmbh focus on?

Sanofi-aventis Deutschland Gmbh's top technology area is A61M (DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY ; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY ; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR) with 1,159 patents. The company has filed patents in 89 CPC subclasses total.

Is Sanofi-aventis Deutschland Gmbh's patent filing rate increasing or decreasing?

Sanofi-aventis Deutschland Gmbh's recent filing velocity is -32% compared to the prior five-year period. Filing activity has slowed relative to earlier years.

What does claim depth mean for Sanofi-aventis Deutschland Gmbh's patents?

Sanofi-aventis Deutschland Gmbh's patents average 16.3 claims each. This falls within the standard range, providing solid legal coverage.

How is the Sanofi-aventis Deutschland Gmbh patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

How to use this portfolio

Sanofi-aventis's 1,348 grants land it in the top 2% by Innovation Score, but volume alone doesn't tell you where the strength sits.

Read that count against the largest US assignees before treating it as dominance - Sanofi-aventis ranks #320 of 50,000. Top 50 holders
Most of this portfolio concentrates in A61M - see who else leads that technology area. A61M leaders
Check what the four-part Innovation Score actually rewards before comparing it to another company. How the score works

Patent counts and the Innovation Score measure patenting activity, not commercial success or the legal strength of any patent. Many patents are filed defensively. Verify the status of an individual patent against official USPTO records.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent Editorial

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled byPlainPatent Editorial, US Patent Intelligence Editorial Team · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.